| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEXIDARTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 1 | ATROPINE INJECTION, 2 MG | 1 | 0.0007 |
| 2 | RIPRETINIB | 2 | 0.0004 |
| 3 | HYDROXYZINE PAMOATE | 1 | 0.0003 |
| 4 | LEVOCARNITINE | 1 | 0.0003 |
| 5 | LANREOTIDE ACETATE | 1 | 0.0001 |
| 6 | PANITUMUMAB | 2 | 0.0001 |
| 7 | TRIFLURIDINE AND TIPIRACIL | 1 | 0.0001 |
| 8 | BENRALIZUMAB | 1 | 0.0000 |
| 9 | NIRAPARIB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3 | 0.0001 |
| 2 | Anticholinergic [EPC] | 1 | 0.0001 |
| 3 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 4 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 5 | Catecholamine [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 7 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 1 | 0.0000 |